MARK SHEPTOFF FINANCIAL PLANNING, LLC - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 54 filers reported holding EDGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$88,000
-32.3%
9,400
-22.3%
0.06%
-34.5%
Q3 2017$130,000
-12.2%
12,100
-16.0%
0.09%
-14.7%
Q2 2017$148,000
+5.7%
14,400
-6.5%
0.10%
+2.0%
Q1 2017$140,000
-29.6%
15,401
-3.1%
0.10%
-32.4%
Q4 2016$199,000
+77.7%
15,900
+47.2%
0.15%
+78.3%
Q3 2016$112,000
+2.8%
10,8000.0%0.08%
+2.5%
Q2 2016$109,000
+1111.1%
10,800
+980.0%
0.08%
+1057.1%
Q1 2016$9,0001,0000.01%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders